masthead-news

News & Events

Nature Research Custom Media webcast: A comparison of gene expression technologies in clinical applications

Dr. Kerry Culm-Merdek of Oncologie and Dr. Marian Navratil of HTG Molecular Diagnostics will describe their cross-platform comparison study between RNA-Seq and HTG’s translational research profiling panel, the HTG EdgeSeq Precision Immuno-Oncology Panel (PIP) for measuring gene expression.

Read More

 

HTG Molecular Diagnostics Reports Second Quarter 2020 Results

Call scheduled for today, August 11, at 4:30pm ET TUCSON, Ariz. , Aug. 11, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the quarter ended June 30, 2020…

Read More

Posted on:
 

HTG Introduces HTG EdgeSeq Reveal RUO Oncology Applications

TUCSON, Ariz. , Aug. 04, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the pre-launch introduction of its new HTG EdgeSeq Reveal RUO oncology applications, which are expected to…

Read More

Posted on:
 

HTG Launches New HTG EdgeSeq Pan B-Cell Lymphoma Panel

TUCSON, Ariz. , July 28, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the launch and immediate availability of the HTG EdgeSeq Pan B-Cell Lymphoma Panel in the United States and…

Read More

Posted on:

Page last updated May 19, 2021